INS and fatty liver disease: Low-dose of clenbuterol enhanced basal in vivo glucose absorption in skeletal muscle and enhanced whole-body insulin sensitivity as well as reduced hepatic steatosis under chronic stimulation of diet-induced obesity (DIO) in mice104.